Cyred EQ®

(desogestrel and ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg

Cyred EQ® is an AB-rated generic oral contraceptive.

Compares to

Apri®, Cyred®, Emoquette®, Enskyce™, Isibloom™, and Reclipsen™

NDC#

50102-254-23

View Full Prescribing Information, Including Boxed Warning

Product Details

  • A progestogen-estrogen combination oral contraceptive
  • Monophasic administration regimen
    • 21 white active tablets containing desogestrel and ethinyl estradiol
    • 7 green placebo tablets to help ease administration

Product Sheet

The Product Information Sheet features a summary of all relevant product information including Cyred EQ® (desogestrel and ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg product details, product description, NDC number, and product features.

Download Now

Product Features:

  • Use of oral contraceptives may increase menstrual cycle regularity, decrease blood loss, and decrease incidence of both iron-deficiency anemia and dysmenorrhea
  • Oral contraceptives may decrease the incidence of functional ovarian cysts and ectopic pregnancies

Breakthrough bleeding and spotting are sometimes encountered in patients on oral contraceptives, especially during the first three months of use. Nonhormonal causes should be considered and adequate diagnostic measures taken to rule out malignancy or pregnancy in the event of breakthrough bleeding. Some women may encounter post-pill amenorrhea or oligomenorrhea, especially when such a condition was pre-existent.

Ectopic as well as intrauterine pregnancy may occur in contraceptive failures.

Common side effects of oral contraceptives include irregular vaginal bleeding or spotting, change in vision or difficulty wearing contact lenses, fluid retention, darkening of the skin, nausea and vomiting, change in appetite, headache, nervousness, depression, dizziness, loss of scalp hair, rash, vaginal infections, and allergic reactions.

The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors.

View Full Prescribing Information, Including Boxed Warning

Distributor & Ordering Info

Cyred EQ®

NDC#: 50102-254-23

Package Size: A Carton Containing 3 Pouches

Distributor Phone URL Order Number
AmerisourceBergen 1-610-727-7000 amerisourcebergen.com 10189510
ANDA 1-800-331-2632 (Ext. 74591) andanet.com 50102025423
ASD Healthcare 1-800-746-6273 asdhealthcare.com 52459
Cardinal Health 1-800-326-6457 cardinalhealth.com 5478516
McKesson 1-855-625-6285 mckesson.com 3564382
Morris & Dickson 1-888-376-7409 morrisdickson.com 392514
R & S Northeast 1-800-262-7770 rsnortheast.com 025423

Order Cyred EQ®
(desogestrel and ethinyl estradiol tablets, USP)

Order Now

Contact Your
Afaxys Pharma
Account Manager

Contact Now

View All
Afaxys Pharma
Products

View Now